Home›Stock Screener›Ortin Global›Quarterly Results

Ortin Global Quarterly Results

Latest Quarter Net Profit
₹-2 Cr
QMar 2012
Quarterly Results

Ortin Global quarterly results. In Mar 2012, Ortin Global (ORTINGLOBE) reported revenue ₹18 Cr and net profit ₹-2 Cr. Review ORTINGLOBE earnings multiple to evaluate earnings-based valuation against sector peers.

ORTINGLOBE Quarterly Results — Revenue, Profit & EPS Highlights

Ortin Global latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check Ortin Global networth to track the company's total market size over time.

  • Revenue of ₹18 Cr in Mar 2012 (+38.5% vs Jun 2012)
  • Net Profit of ₹-2 Cr in Mar 2012
  • EBITDA of ₹-3 Cr in Mar 2012 (-200.0% vs Jun 2012)
  • Operating Margin of -19.0% in Mar 2012 (-14.0pp vs Jun 2012)
  • Earnings Per Share of ₹-1.13 in Mar 2012 (-534.6% vs Jun 2012)

Ortin Global Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ORTINGLOBE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2012 Jun 2012 QoQ YoY
Revenue (₹ Cr) 18 13 38.5% -
Net Profit (₹ Cr) -2 0 - -
EBITDA (₹ Cr) -3 -1 - -
EPS (₹) -1.13 0.26 - -
Operating Margin (%) -19.0% -5.0% - -

ORTINGLOBE Share Price Trend — 1-Year Movement Across Quarterly Results

Ortin Global 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit ORTINGLOBE share price screener.

Profitability Ratios

Profit Margin -11.1%
EBITDA Margin -16.7%
Operating Margin -19.0%
ROE (Annual) -800.0%

Balance Sheet Highlights

Total Assets ₹5 Cr
Total Equity ₹1 Cr
Current Assets ₹4 Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹-1 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹1 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹13.82
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Jun 2012 13
Mar 2012 18

Net Profit Trend (₹ Cr)

Jun 2012 0
Mar 2012 -2

Operating Margin Trend (%)

Jun 2012 -5.0%
Mar 2012 -19.0%

ORTINGLOBE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Ortin Global latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores